Martin Bauer

3.3k total citations
100 papers, 2.4k citations indexed

About

Martin Bauer is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Martin Bauer has authored 100 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 42 papers in Pediatrics, Perinatology and Child Health and 31 papers in Psychiatry and Mental health. Recurrent topics in Martin Bauer's work include Drug Transport and Resistance Mechanisms (49 papers), Pharmacological Effects and Toxicity Studies (40 papers) and Epilepsy research and treatment (22 papers). Martin Bauer is often cited by papers focused on Drug Transport and Resistance Mechanisms (49 papers), Pharmacological Effects and Toxicity Studies (40 papers) and Epilepsy research and treatment (22 papers). Martin Bauer collaborates with scholars based in Austria, Germany and France. Martin Bauer's co-authors include Oliver Langer, Markus Zeitlinger, Rudolf Karch, Markus Müller, Hartmut J. Ehrlich, Walter Jäger, Johann Stanek, Wolfgang Wadsak, Nicolas Tournier and Marcus Hacker and has published in prestigious journals such as New England Journal of Medicine, NeuroImage and Brain.

In The Last Decade

Martin Bauer

93 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Bauer Austria 28 1.1k 787 545 361 320 100 2.4k
Jan den Hartigh Netherlands 36 768 0.7× 559 0.7× 189 0.3× 772 2.1× 248 0.8× 99 3.8k
C. Philippe Austria 26 537 0.5× 196 0.2× 182 0.3× 496 1.4× 162 0.5× 145 2.3k
Ling Shen United States 34 253 0.2× 200 0.3× 226 0.4× 1.1k 3.1× 651 2.0× 132 3.7k
Michel Morre France 30 935 0.8× 215 0.3× 217 0.4× 624 1.7× 1.0k 3.2× 61 4.8k
O. Kristensen Denmark 33 239 0.2× 312 0.4× 382 0.7× 944 2.6× 121 0.4× 93 2.6k
Hitoshi Tada Japan 24 379 0.3× 411 0.5× 113 0.2× 238 0.7× 136 0.4× 96 1.9k
John Posner United Kingdom 26 275 0.2× 382 0.5× 455 0.8× 302 0.8× 283 0.9× 80 2.0k
Kelvin Y.K. Chan Hong Kong 37 594 0.5× 481 0.6× 186 0.3× 1.7k 4.6× 406 1.3× 132 3.8k
Simon M. Jarvis United Kingdom 41 862 0.8× 1.0k 1.3× 142 0.3× 1.7k 4.7× 706 2.2× 110 4.4k
D Müller Germany 32 634 0.6× 256 0.3× 723 1.3× 1.1k 3.0× 152 0.5× 86 3.5k

Countries citing papers authored by Martin Bauer

Since Specialization
Citations

This map shows the geographic impact of Martin Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bauer more than expected).

Fields of papers citing papers by Martin Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bauer. The network helps show where Martin Bauer may publish in the future.

Co-authorship network of co-authors of Martin Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bauer. A scholar is included among the top collaborators of Martin Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bauer. Martin Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krenn, Katharina, Matthias Urban, Roman Ullrich, et al.. (2025). Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trial. Anaesthesia Critical Care & Pain Medicine. 44(3). 101520–101520.
2.
Rabl, Ulrich, Martin Bauer, Edith Lackner, et al.. (2025). Cerebrospinal fluid concentrations of ceftaroline and ceftazidime/avibactam in healthy volunteers: Pharmacokinetics and probability of target attainment. International Journal of Antimicrobial Agents. 66(2). 107512–107512.
3.
4.
Bauer, Martin, Iris K. Minichmayr, Birgit Reiter, et al.. (2024). Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study. British Journal of Clinical Pharmacology. 91(3). 808–816.
5.
Bauer, Martin, Eric P. Tamm, Marcus Hacker, et al.. (2024). Development of quantitative PET/MR imaging for measurements of hepatic portal vein input function: a phantom study. EJNMMI Physics. 11(1). 90–90. 1 indexed citations
6.
Vodovar, Dominique, Solène Marie, Sylvain Auvity, et al.. (2023). Parametric Imaging of P-Glycoprotein Function at the Blood–Brain Barrier Using kE,brain-maps Generated from [11C]Metoclopramide PET Data in Rats, Nonhuman Primates and Humans. Molecular Imaging and Biology. 25(6). 1135–1141. 3 indexed citations
7.
Schmidl, Doreen, et al.. (2021). The Effect of Orally Administered Low-Dose Dronabinol on Retinal Blood Flow and Oxygen Metabolism in Healthy Subjects. Journal of Ocular Pharmacology and Therapeutics. 37(6). 360–366. 4 indexed citations
8.
Tournier, Nicolas, Martin Bauer, Verena Pichler, et al.. (2019). Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans. Journal of Nuclear Medicine. 60(7). 985–991. 38 indexed citations
9.
Goutal, Sébastien, Solène Marie, Fabien Caillé, et al.. (2018). Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats. EJNMMI Research. 8(1). 81–81. 12 indexed citations
10.
Matzneller, Peter, Manuel Kussmann, Alexandra Maier‐Salamon, et al.. (2018). Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. European Journal of Drug Metabolism and Pharmacokinetics. 43(5). 599–606. 24 indexed citations
11.
Bauer, Martin, Lucie Bartova, N. Praschak-Rieder, et al.. (2016). Making Sense of: Sensitization in Schizophrenia. The International Journal of Neuropsychopharmacology. 20(1). 1–10. 35 indexed citations
12.
Bauer, Martin, Rudolf Karch, Nicolas Tournier, et al.. (2016). Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐11C-Verapamil PET. Journal of Nuclear Medicine. 58(4). 678–681. 24 indexed citations
13.
Bauer, Martin, Rudolf Karch, Markus Zeitlinger, et al.. (2013). Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood–Brain Barrier. Journal of Nuclear Medicine. 54(8). 1181–1187. 43 indexed citations
14.
Bauer, Martin, Markus Zeitlinger, Michaela Böhmdorfer, et al.. (2012). Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects. Pharmacology. 91(1-2). 12–19. 22 indexed citations
15.
Prymula, Roman, Martin Bauer, Borislava G. Pavlova, et al.. (2012). Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior. Human Vaccines & Immunotherapeutics. 8(6). 736–742. 17 indexed citations
16.
Bauer, Martin, H Bliesath, Chiara Leuratti, et al.. (2010). Disposition and Metabolism of Ralfinamide, a Novel Na-Channel Blocker, in Healthy Male Volunteers. Pharmacology. 86(5-6). 297–305. 6 indexed citations
17.
Wagner, Cláudia, Martin Bauer, Rudolf Karch, et al.. (2009). A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET. Journal of Nuclear Medicine. 50(12). 1954–1961. 89 indexed citations
18.
Bauer, Martin, Cláudia Wagner, & Oliver Langer. (2008). Microdosing Studies in Humans. Drugs in R&D. 9(2). 73–81. 29 indexed citations
19.
Abrahim, Aiman, Gert Luurtsema, Martin Bauer, et al.. (2007). Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients. European Journal of Nuclear Medicine and Molecular Imaging. 35(1). 116–123. 33 indexed citations
20.
Bauer, Martin, Oliver Langer, Peter Dal‐Bianco, et al.. (2006). A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer’s disease. Clinical Pharmacology & Therapeutics. 80(3). 216–227. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan den Hartigh Breakdown of academic impact, for papers by C. Philippe Breakdown of academic impact, for papers by Ling Shen Breakdown of academic impact, for papers by Michel Morre Breakdown of academic impact, for papers by O. Kristensen Breakdown of academic impact, for papers by Hitoshi Tada Breakdown of academic impact, for papers by John Posner Breakdown of academic impact, for papers by Kelvin Y.K. Chan Breakdown of academic impact, for papers by Simon M. Jarvis Breakdown of academic impact, for papers by D Müller
Rankless by CCL
2026